HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

N Takasu Selected Research

Lymphoma (Lymphomas)

1/2005Sensitivity of adult T-cell leukaemia lymphoma cells to tumour necrosis factor-related apoptosis-inducing ligand.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


N Takasu Research Topics

Disease

4Hyperthyroidism
11/2001 - 10/2000
3Graves Disease (Basedow Disease)
06/2007 - 10/2000
3Hypothyroidism
07/2006 - 08/2000
3Obesity
03/2005 - 01/2000
2Type 2 Diabetes Mellitus (MODY)
05/2007 - 01/2000
2Body Weight (Weight, Body)
05/2002 - 01/2000
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2001 - 04/2000
1Left Ventricular Dysfunction
05/2007
1Tuberculous Peritonitis
07/2006
1Lymphadenopathy
07/2006
1Ascites
07/2006
1Granuloma
07/2006
1Thyroiditis
07/2006
1Liver Abscess
07/2006
1Insulinoma
03/2006
1Hyperglycemia
03/2005
1Myotonic Dystrophy (Dystrophia Myotonica)
03/2005
1Lymphoma (Lymphomas)
01/2005
1Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
01/2005
1Necrosis
01/2005
1Neoplasms (Cancer)
01/2005
1Pain (Aches)
09/2004
1Diabetic Neuropathies (Diabetic Neuropathy)
09/2004
1Hepatitis B
11/2003
1Pancreatitis
11/2003
1Glucose Intolerance
12/2001
1Cardiomegaly (Heart Hypertrophy)
11/2001
1Myocardial Stunning (Stunned Myocardium)
09/2001
1Teratocarcinoma
03/2001
1Diabetes Mellitus
01/2001
1Cranial Nerve Diseases (Cranial Nerve Disorders)
12/2000
1Hypoglycemia (Reactive Hypoglycemia)
04/2000
1Hypertension (High Blood Pressure)
03/2000
1Morbid Obesity
01/2000

Drug/Important Bio-Agent (IBA)

3Insulin (Novolin)FDA Link
03/2005 - 04/2000
2Immunoglobulin E (IgE)IBA
06/2007 - 08/2001
2Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
11/2001 - 03/2000
2Thyroxine (Levothyroxine)FDA LinkGeneric
11/2001 - 08/2000
2Thyroid-Stimulating ImmunoglobulinsIBA
04/2001 - 10/2000
2thyroid stimulation-blocking antibodyIBA
04/2001 - 08/2000
1InterleukinsIBA
06/2007
1Brain Natriuretic Peptide (Natrecor)FDA Link
05/2007
1Rifampin (Rifampicin)FDA LinkGeneric
07/2006
1Eosine Yellowish-(YS) (Eosin)IBA
03/2006
1Coloring Agents (Dyes)IBA
03/2006
1PalmitatesIBA
03/2006
1Oleic Acid (Oleate)IBA
03/2006
1Metformin (Glucophage)FDA LinkGeneric
03/2005
1Glucose (Dextrose)FDA LinkGeneric
03/2005
1TNF-Related Apoptosis-Inducing LigandIBA
01/2005
1Death Domain ReceptorsIBA
01/2005
1Caspase 8 (Caspase-8)IBA
01/2005
1LigandsIBA
01/2005
1Nitroglycerin (Dynamite)FDA LinkGeneric
09/2004
1Prednisolone (Predate)FDA LinkGeneric
11/2003
1Pro-Opiomelanocortin (Proopiomelanocortin)IBA
05/2002
1Peptides (Polypeptides)IBA
05/2002
1CilazaprilIBA
11/2001
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
11/2001
1Drinking WaterIBA
11/2001
1Propranolol (Inderal)FDA LinkGeneric
11/2001
1CalciumIBA
09/2001
1Streptozocin (Streptozotocin)FDA Link
09/2001
1Triiodothyronine (Liothyronine)FDA LinkGeneric
09/2001
1Methimazole (Thiamazole)FDA LinkGeneric
08/2001
1Interleukin-13IBA
08/2001
1LuciferasesIBA
03/2001
1Codon (Codons)IBA
01/2001
1Methionine (L-Methionine)FDA Link
01/2001
1K-18 conjugate (K18)IBA
01/2001
1SuperantigensIBA
01/2001
1AntibodiesIBA
10/2000
1Thyrotropin Receptors (Thyrotropin Receptor)IBA
10/2000
1Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
10/2000
1Antithyroid Agents (Antithyroid Drugs)IBA
10/2000
1Immunoglobulins (Immunoglobulin)IBA
10/2000
1Glycoside Hydrolase InhibitorsIBA
04/2000
1voglibose (Basen)IBA
04/2000
1Cytochrome P-450 CYP11B2 (CYP11B2)IBA
03/2000
1AldosteroneIBA
03/2000
1ReninIBA
03/2000
1Genetic Markers (Genetic Marker)IBA
01/2000
1LeptinIBA
01/2000
1Proteins (Proteins, Gene)FDA Link
01/2000

Therapy/Procedure

3Therapeutics
01/2005 - 04/2000
1Intraperitoneal Injections
11/2001
1Conservative Treatment
12/2000